Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Apple
AAPL
|
+$652M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$518M |
| 3 |
iShares MBS ETF
MBB
|
+$406M |
| 4 |
Procter & Gamble
PG
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$351M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$642M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$570M |
| 3 |
Sempra
SRE
|
+$490M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| 1 | Technology | 17.54% |
| 2 | Healthcare | 11.42% |
| 3 | Financials | 10.41% |
| 4 | Consumer Discretionary | 9.33% |
| 5 | Communication Services | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Cytosorbents Corp
CTSO
$58.9M
| $118K | ﹤0.01% |
30,621
+15,453
| +102% | +$59.5K |
|
|
OTRK
3302
DELISTED
Ontrak
OTRK
| $118K | ﹤0.01% |
80
+37
| +86% | +$54.6K |
|
|
ENZ
3303
DELISTED
Enzo Biochem, Inc.
ENZ
| $118K | ﹤0.01% |
44,979
+22,067
| +96% | +$57.9K |
|
3304
BioLife Solutions
BLFS
$1.22B
| $117K | ﹤0.01% |
7,260
+401
| +6% | +$6.46K |
|
3305
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$395M
| $117K | ﹤0.01% |
2,667
| – | – |
|
3306
Saga Communications
SGA
$77.3M
| $117K | ﹤0.01% |
3,875
+3,866
| +42,956% | +$117K |
|
|
XNET
3307
Xunlei
XNET
$472M
| $117K | ﹤0.01% |
23,900
-169,604
| -88% | -$830K |
|
|
SHSP
3308
DELISTED
SharpSpring, Inc.
SHSP
| $117K | ﹤0.01% |
10,224
+5,184
| +103% | +$59.3K |
|
3309
Pegasystems
PEGA
$9.93B
| $116K | ﹤0.01% |
2,932
-71,964
| -96% | -$2.85M |
|
3310
Twin Disc
TWIN
$187M
| $116K | ﹤0.01% |
10,525
+5,272
| +100% | +$58.1K |
|
3311
Galectin Therapeutics
GALT
$344M
| $115K | ﹤0.01% |
40,060
+20,188
| +102% | +$58K |
|
3312
GSI Technology
GSIT
$98M
| $115K | ﹤0.01% |
16,179
+8,125
| +101% | +$57.8K |
|
3313
iShares Global Energy ETF
IXC
$1.84B
| $115K | ﹤0.01% |
3,737
| – | – |
|
3314
Astrana Health
ASTH
$1.38B
| $115K | ﹤0.01% |
6,249
-7,541
| -55% | -$139K |
|
3315
First Guaranty Bancshares
FGBI
$123M
| $114K | ﹤0.01% |
5,777
+2,901
| +101% | +$57.2K |
|
3316
Fonar
FONR
$98.8M
| $114K | ﹤0.01% |
5,802
-6
| -0.1% | -$118 |
|
3317
Mustang Bio
MBIO
$11.4M
| $114K | ﹤0.01% |
37
+19
| +106% | +$58.5K |
|
3318
Wrap Technologies
WRAP
$104M
| $114K | ﹤0.01% |
17,831
+13,735
| +335% | +$87.8K |
|
3319
Corporacion America
CAAP
$3.16B
| $113K | ﹤0.01% |
18,800
-6,965
| -27% | -$41.9K |
|
|
CRESY
3320
Cresud
CRESY
$518M
| $113K | ﹤0.01% |
16,687
-18,556
| -53% | -$126K |
|
3321
Akero Therapeutics
AKRO
$3.48B
| $112K | ﹤0.01% |
5,018
+2,361
| +89% | +$52.7K |
|
3322
Transportadora de Gas del Sur
TGS
$3.18B
| $112K | ﹤0.01% |
15,653
-583
| -4% | -$4.17K |
|
3323
Altisource Portfolio Solutions
ASPS
$123M
| $111K | ﹤0.01% |
722
+291
| +68% | +$44.7K |
|
3324
Anavex Life Sciences
AVXL
$805M
| $111K | ﹤0.01% |
42,939
+21,777
| +103% | +$56.3K |
|
|
MRNS
3325
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $111K | ﹤0.01% |
12,867
-1,891
| -13% | -$16.3K |
|